OSMOPREP
Total Payments
$728,624
Transactions
27
Doctors
1
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $75,000 | 3 | 1 |
| 2022 | $100,000 | 4 | 1 |
| 2021 | $100,000 | 4 | 1 |
| 2020 | $100,664 | 4 | 1 |
| 2019 | $113,062 | 4 | 1 |
| 2018 | $126,506 | 4 | 1 |
| 2017 | $113,392 | 4 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $728,624 | 27 | 100.0% |
Top Doctors Receiving Payments for OSMOPREP
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Gastroenterology | Conshohocken, PA | $728,624 | 27 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $728,624
- Total Doctors 1
- Transactions 27
About OSMOPREP
OSMOPREP is a drug associated with $728,624 in payments to 1 healthcare providers, recorded across 27 transactions in the CMS Open Payments database. The primary manufacturer is Salix Pharmaceuticals, a division of Bausch Health US, LLC.
Payment data is available from 2017 to 2023. In 2023, $75,000 was paid across 3 transactions to 1 doctors.
The most common payment nature for OSMOPREP is "Royalty or License" ($728,624, 100.0% of total).